Nutra Pharma Announces the Launch of MyNyloxin.com for Nyloxin Sales Through Their Network Marketing Distributors
06 déc. 2013 14h22 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Dec 6, 2013) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple...
Nutra Pharma Finalizes Exclusive Network Marketing Distribution Agreement for Nyloxin
02 déc. 2013 08h00 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Dec 2, 2013) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma to Present at Upcoming Investment Conference
18 nov. 2013 14h38 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Nov 18, 2013) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Provides Updates for the Marketing of Its All-Natural Pain Reliever, Nyloxin(R)
11 nov. 2013 08h00 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Nov 11, 2013) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...
Nutra Pharma Announces Launch of Equine Nyloxin(R) for Use in Horses
30 oct. 2013 08h00 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Oct 30, 2013) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...
Nutra Pharma Announces Updated Interviews With Wall Street Buy Sell Hold
22 oct. 2013 08h00 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Oct 22, 2013) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human...
P2D Bioscience Receives NIH Funding to Develop Drugs for Lung Disease
19 juil. 2011 10h31 HE
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jul 19, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, announced today that the company has received a $320,000 grant from...